cbdMD (YCBD) Revenue Growth (5y) (2021 - 2025)
cbdMD (YCBD) Revenue Growth (5y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.39 Bn | 30.45 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.00 Bn | 16.69 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | cbdMD | 4.87 Mn | 1.48 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.51% |
| Sep 30, 2025 | -18.33% |
| Jun 30, 2025 | -15.68% |
| Mar 31, 2025 | -12.76% |
| Dec 31, 2024 | -13.26% |
| Sep 30, 2024 | -12.70% |
| Jun 30, 2024 | -11.87% |
| Mar 31, 2024 | -10.81% |
| Dec 31, 2023 | 51.04% |
| Sep 30, 2023 | 21.94% |
| Jun 30, 2023 | 27.01% |
| Mar 31, 2023 | 15.12% |
| Dec 31, 2022 | 54.74% |
| Sep 30, 2022 | 51.95% |
| Jun 30, 2022 | 44.72% |
| Mar 31, 2022 | 53.23% |
| Dec 31, 2021 | 118.08% |